Covered recipient · General Payments record
BETH SCHROEDER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,957.00
- Reported across 199 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $519.34 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $299.03 | 13 |
| Merck Sharp & Dohme Corporation | $47.97 | 3 |
| Novo Nordisk AS | $36.81 | 2 |
| PFIZER INC. | $31.50 | 2 |
| Otsuka America Pharmaceutical, Inc. | $24.80 | 1 |
| Astellas Pharma US Inc | $18.61 | 1 |
| Corium, Inc. | $16.02 | 2 |
| DEXCOM, INC. | $15.70 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.38 | 1 |
| Vanda Pharmaceuticals Inc. | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.87 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041502 | CMS |
| ABBVIE INC. | $16.72 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041504 | CMS |
| ABBVIE INC. | $20.15 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041506 | CMS |
| ABBVIE INC. | $32.11 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041508 | CMS |
| ABBVIE INC. | $24.47 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041510 | CMS |
| ABBVIE INC. | $12.88 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041512 | CMS |
| ABBVIE INC. | $34.30 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041514 | CMS |
| ABBVIE INC. | $21.84 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041516 | CMS |
| ABBVIE INC. | $14.36 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041518 | CMS |
| ABBVIE INC. | $17.73 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041520 | CMS |
| ABBVIE INC. | $33.74 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041522 | CMS |
| ABBVIE INC. | $14.54 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041524 | CMS |
| ABBVIE INC. | $31.32 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106041526 | CMS |
| Astellas Pharma US Inc | $18.61 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139341728 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.38 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117906466 | CMS |
| Corium, LLC | $1.09 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100140113 | CMS |
| Corium, LLC | $14.93 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100164255 | CMS |
| Dexcom, Inc. | $15.70 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153286205 | CMS |
| Merck Sharp & Dohme LLC | $16.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141817533 | CMS |
| Merck Sharp & Dohme LLC | $14.76 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141817531 | CMS |
| Merck Sharp & Dohme LLC | $17.18 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141948466 | CMS |
| Novo Nordisk Inc | $17.65 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097667833 | CMS |
| Novo Nordisk Inc | $19.16 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097728934 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.80 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118977688 | CMS |
| PFIZER INC. | $16.67 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130944711 | CMS |
| PFIZER INC. | $14.83 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131979756 | CMS |
| Vanda Pharmaceuticals Inc. | $13.52 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133919399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.